Literature DB >> 14612508

Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.

Michael Milyavsky1, Igor Shats, Neta Erez, Xiaohu Tang, Shai Senderovich, Ari Meerson, Yuval Tabach, Naomi Goldfinger, Doron Ginsberg, Curtis C Harris, Varda Rotter.   

Abstract

Telomere shortening in primary human fibroblasts results in replicative senescence, which can be overcome by telomerase (hTERT) overexpression. However, because immortalization is one of the hallmarks of malignant transformation, careful analysis of hTERT-immortalized cells is of crucial importance for understanding both processes. To this end, we infected WI-38 fibroblasts with a retrovirus carrying the hTERT cDNA and analyzed their proliferative behavior during 600 days [ approximately 500 population doublings (PDLs)] of continuous culture. Growth of three independent mass cultures was uniform for approximately 150 PDLs after telomerase infection, followed by a progressive acceleration of growth in two of three cultures. Expression of p16(INK4A) was significantly elevated in the immortalized cells but gradually disappeared during the accelerated growth phase. This alteration correlated with loss of the contact inhibition response and conferred the cells with sensitivity to H-Ras-induced transformation. In contrast, the p53- and pRb-mediated checkpoints such as the DNA damage response, chromosomal stability and entry into quiescence remained intact, irrespective of INK4A locus expression. Importantly, detailed examination of one of the WI-38/hTERT cultures during the accelerated growth phase revealed overexpression of the c-myc and Bmi-1 oncogenes, as well as loss of p14(ARF) expression. Collectively, our results indicate that although hTERT-immortalized cells behave similarly to primary cells during the first 150 PDLs, long-term growth in culture may favor the appearance of clones carrying potentially malignant alterations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612508

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.

Authors:  Yael Aylon; Yaara Ofir-Rosenfeld; Norikazu Yabuta; Eleonora Lapi; Hiroshi Nojima; Xin Lu; Moshe Oren
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

2.  Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.

Authors:  Xuefeng Liu; Aleksandra Dakic; Renxiang Chen; Gary L Disbrow; Yiyu Zhang; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

3.  Endothelial matrix assembly during capillary morphogenesis: insights from chimeric TagRFP-fibronectin matrix.

Authors:  Fumin Chang; Christopher A Lemmon; Voraphoj Nilaratanakul; Varda Rotter; Lewis Romer
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

4.  SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63.

Authors:  Chamutal Bornstein; Ran Brosh; Alina Molchadsky; Shalom Madar; Ira Kogan-Sakin; Ido Goldstein; Deepavali Chakravarti; Elsa R Flores; Naomi Goldfinger; Rachel Sarig; Varda Rotter
Journal:  Mol Cell Biol       Date:  2011-02-07       Impact factor: 4.272

5.  Expression profile of the stem cell markers in human Hertwig's epithelial root sheath/Epithelial rests of Malassez cells.

Authors:  Hyun Nam; Jaewon Kim; Jaewan Park; Joo-Cheol Park; Jung-Wook Kim; Byoung-Moo Seo; Jae Cheoun Lee; Gene Lee
Journal:  Mol Cells       Date:  2011-02-22       Impact factor: 5.034

6.  Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues.

Authors:  Gilad Landan; Netta Mendelson Cohen; Zohar Mukamel; Amir Bar; Alina Molchadsky; Ran Brosh; Shirley Horn-Saban; Daniela Amann Zalcenstein; Naomi Goldfinger; Adi Zundelevich; Einav Nili Gal-Yam; Varda Rotter; Amos Tanay
Journal:  Nat Genet       Date:  2012-10-14       Impact factor: 38.330

7.  A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.

Authors:  Yosef Buganim; Ido Goldstein; Doron Lipson; Michael Milyavsky; Sylvie Polak-Charcon; Corine Mardoukh; Hilla Solomon; Eyal Kalo; Shalom Madar; Ran Brosh; Marina Perelman; Roy Navon; Naomi Goldfinger; Iris Barshack; Zohar Yakhini; Varda Rotter
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

8.  Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A).

Authors:  Michal Barzily-Rokni; Nathalie Friedman; Shulamit Ron-Bigger; Sara Isaac; Dan Michlin; Amir Eden
Journal:  Nucleic Acids Res       Date:  2010-10-28       Impact factor: 16.971

9.  Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress.

Authors:  Chin-Yi Kan; Carlotta Petti; Lauryn Bracken; Michelle Maritz; Ning Xu; Rosemary O'Brien; Chen Yang; Tao Liu; Jun Yuan; Richard B Lock; Karen L MacKenzie
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

10.  Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation.

Authors:  Y Aylon; N Yabuta; H Besserglick; Y Buganim; V Rotter; H Nojima; M Oren
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.